Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). (Q34544500)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). |
scientific article |
Statements
1 reference
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). (English)
1 reference
Vibeke Strand
1 reference
Daniel E Furst
1 reference
Michael H Schiff
1 reference
Roy M Fleischmann
1 reference
Charles A Birbara
1 reference
Daniele Compagnone
1 reference
Steven A Fischkoff
1 reference
Elliot K Chartash
1 reference
1 December 2003
1 reference
1 reference
30
1 reference
12
1 reference
2563-2571
1 reference
Identifiers
1 reference